Reported Jun 21, 2023 · Terminated
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals…
Amring Pharmaceuticals Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Amring Pharmaceuticals Inc · 1205 Westlakes Dr Ste 275 · Berwyn, PA · 19312-2411
Is this the product you have?
- Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only
- Manufactured for
Amring Pharmaceuticals Inc. BerwynPA 19312NDC 69918-301-30
- Lot codes and dates
- Lots
X220317A and X220318Aexp. date 09/25
- Lots
- Amount recalled
- 48,989 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Amring Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.